Picture of Adaptimmune Therapeutics logo

ADAP — Adaptimmune Therapeutics Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for Adaptimmune Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments
Net Total Accounts Receivable
Net Total Receivables
Prepaid Expenses
Total Other Current Assets
Total Current Assets
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment
Net Intangible Assets
Other Long Term Assets
Total Assets
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity
Total Liabilities & Shareholders' Equity
Total Common Shares Outstanding

Or unlock with your email

Or unlock with your email